Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
71.3 CHF | +2.00% | +12.28% | +40.08% |
Mar. 20 | Transcript : Cosmo Pharmaceuticals N.V. - Analyst/Investor Day | |
Mar. 20 | Cosmo Pharmaceuticals N.V. Proposes Dividend Payment for 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+40.08% | 1.27B | |
+33.46% | 701B | |
+26.24% | 570B | |
+0.93% | 381B | |
+21.03% | 334B | |
+17.51% | 322B | |
+2.95% | 212B | |
+0.74% | 209B | |
-6.05% | 205B | |
-3.61% | 157B |
- Stock
- Equities
- Stock Cosmo Pharmaceuticals N.V. - Swiss Exchange
- News Cosmo Pharmaceuticals N.V.
- Cosmo Pharmaceuticals Partner Medtronic to Install Colon Cancer Screening Devices for US Veterans